HUP0001165A2 - NK1 és NK2 antagonista hatású acil-amino-alkil-amid-származékok, a vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra - Google Patents

NK1 és NK2 antagonista hatású acil-amino-alkil-amid-származékok, a vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra

Info

Publication number
HUP0001165A2
HUP0001165A2 HU0001165A HUP0001165A HUP0001165A2 HU P0001165 A2 HUP0001165 A2 HU P0001165A2 HU 0001165 A HU0001165 A HU 0001165A HU P0001165 A HUP0001165 A HU P0001165A HU P0001165 A2 HUP0001165 A2 HU P0001165A2
Authority
HU
Hungary
Prior art keywords
lower alkyl
group
hydrogen atom
acylaminoalkenylene
antagonists
Prior art date
Application number
HU0001165A
Other languages
English (en)
Inventor
Marc Gerspacher
Robert Mah
Silvio Roggo
Andreas Sprecher
Stefan Stutz
Original Assignee
Novartis Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag. filed Critical Novartis Ag.
Publication of HUP0001165A2 publication Critical patent/HUP0001165A2/hu
Publication of HUP0001165A3 publication Critical patent/HUP0001165A3/hu
Publication of HU226395B1 publication Critical patent/HU226395B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/12—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A találmány tárgya (I) általános képletű vegyületek, ahol R jelentése adott esetben 1, 2 vagy 3 halogénatommal, rövid szénláncúalkil-, trifluor-metil-, hidroxil- vagy rövid szénláncúalkoxicsoporttal szubsztituált fenilcsoport, R1 jelentése hidrogénatom vagy rövid szénláncú alkilcsoport, R2 jelentése hidrogénatom, rövid szénláncú alkil- vagy adott esetben1, 2 vagy 3 halogénatommal, rövid szénláncú alkil-, trifluor-metil-,hidroxil- vagy rövid szénláncú alkoxicsoporttal szubsztituáltfenilcsoport, R3 jelentése adott esetben 1, 2 vagy 3 halogénatommal, rövid szénláncúalkil-, trifluor-metil-, hidroxil- vagy rövid szénláncúalkoxicsoporttal szubsztituált fenilcsoport; vagy naftil-, 1H-indol-3-il- vagy 1-(rövid szénláncú alkil)-indol-3-il-csoport, R4' és R4 jelentése egymástól függetlenül hidrogénatom vagy rövidszénláncú alkilcsoport, R4' és R4 közül legalább az egyik jelentésehidrogénatom, és R5 jelentése 3-8 szénatomos cikloalkil, D-azaciklo-heptán-2-on-3-il-vagy L-azaciklo-heptán-2-on-3-il-csoport, és sói. Ó
HU0001165A 1996-08-22 1997-08-13 Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists, pharmaceutical compositions containing them and process for producing them HU226395B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH206196 1996-08-22
PCT/EP1997/004436 WO1998007694A1 (en) 1996-08-22 1997-08-13 Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists

Publications (3)

Publication Number Publication Date
HUP0001165A2 true HUP0001165A2 (hu) 2000-11-28
HUP0001165A3 HUP0001165A3 (en) 2002-02-28
HU226395B1 HU226395B1 (en) 2008-11-28

Family

ID=4225003

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0001165A HU226395B1 (en) 1996-08-22 1997-08-13 Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists, pharmaceutical compositions containing them and process for producing them

Country Status (32)

Country Link
US (1) US6319917B1 (hu)
EP (1) EP0923550B1 (hu)
JP (1) JP3654908B2 (hu)
KR (1) KR100467402B1 (hu)
CN (1) CN1119328C (hu)
AR (1) AR009266A1 (hu)
AT (1) ATE224875T1 (hu)
AU (1) AU721850B2 (hu)
BR (1) BR9711350A (hu)
CA (1) CA2264065C (hu)
CO (1) CO4900047A1 (hu)
CZ (1) CZ294233B6 (hu)
DE (1) DE69715886T2 (hu)
DK (1) DK0923550T3 (hu)
ES (1) ES2184083T3 (hu)
HK (1) HK1021372A1 (hu)
HU (1) HU226395B1 (hu)
ID (1) ID18059A (hu)
IL (1) IL128631A (hu)
MY (1) MY132550A (hu)
NO (1) NO312292B1 (hu)
NZ (1) NZ334736A (hu)
PE (1) PE107498A1 (hu)
PL (1) PL193731B1 (hu)
PT (1) PT923550E (hu)
RU (1) RU2185375C2 (hu)
SI (1) SI0923550T1 (hu)
SK (1) SK283991B6 (hu)
TR (1) TR199900363T2 (hu)
TW (1) TW438777B (hu)
WO (1) WO1998007694A1 (hu)
ZA (1) ZA977493B (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6281300B1 (en) * 1998-03-20 2001-08-28 Exxon Chemical Patents, Inc. Continuous slurry polymerization volatile removal
GB0010958D0 (en) * 2000-05-05 2000-06-28 Novartis Ag Organic compounds
GB0203061D0 (en) 2002-02-08 2002-03-27 Novartis Ag Organic compounds
GB2394417A (en) * 2002-10-24 2004-04-28 Novartis Ag Solid dispersion comprising a piperidine substance P antagonist and a carrier
GB0224788D0 (en) * 2002-10-24 2002-12-04 Novartis Ag Organic compounds
CN1874766A (zh) 2003-10-27 2006-12-06 诺瓦提斯公司 神经激肽拮抗剂在尿失禁治疗中的用途
EP1691814B9 (en) * 2003-12-01 2013-02-20 Cambridge Enterprise Limited Anti-inflammatory agents
GB0402679D0 (en) * 2004-02-06 2004-03-10 Novartis Ag Organic compounds
JO2630B1 (en) * 2006-04-13 2012-06-17 نوفارتيس ايه جي Organic compounds
GB0607532D0 (en) * 2006-04-13 2006-05-24 Novartis Ag Organic compounds
EP1938804A1 (en) * 2006-12-22 2008-07-02 Novartis AG Pharmaceutical formulation comprising neurokinin antagonist
EP2117538A1 (en) 2007-01-24 2009-11-18 Glaxo Group Limited Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-)
UA105182C2 (ru) 2008-07-03 2014-04-25 Ньюрексон, Інк. Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность
US20120077803A1 (en) * 2009-02-24 2012-03-29 Novartis Ag Uses Of NK Receptor Antagonists
RU2697414C1 (ru) * 2018-05-11 2019-08-14 Общество с ограниченной ответственностью "АЙ БИ ДИ Терапевтикс" Новый антагонист тахикининовых рецепторов и его применение

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5472978A (en) 1991-07-05 1995-12-05 Merck Sharp & Dohme Ltd. Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
MY110227A (en) * 1991-08-12 1998-03-31 Ciba Geigy Ag 1-acylpiperindine compounds.
US5217996A (en) 1992-01-22 1993-06-08 Ciba-Geigy Corporation Biaryl substituted 4-amino-butyric acid amides
EP0716077A1 (de) * 1994-12-08 1996-06-12 Ciba-Geigy Ag Aromatisch substituierte Omega-Aminoalkansäureamide und Alkansäurediamide und ihre Verwendung als Renininhibitoren
CZ288345B6 (en) 1995-02-22 2001-05-16 Novartis Ag Arylacylaminoethanes, process of their preparation and pharmaceutical preparation in which they are comprised

Also Published As

Publication number Publication date
AR009266A1 (es) 2000-04-12
JP2001503387A (ja) 2001-03-13
CN1119328C (zh) 2003-08-27
ATE224875T1 (de) 2002-10-15
ZA977493B (en) 1998-08-03
EP0923550A1 (en) 1999-06-23
PL193731B1 (pl) 2007-03-30
AU4299397A (en) 1998-03-06
US6319917B1 (en) 2001-11-20
HK1021372A1 (en) 2000-06-09
NO990786L (no) 1999-03-25
SI0923550T1 (en) 2003-02-28
PE107498A1 (es) 1999-01-28
WO1998007694A1 (en) 1998-02-26
PL331740A1 (en) 1999-08-02
KR100467402B1 (ko) 2005-01-24
RU2185375C2 (ru) 2002-07-20
TR199900363T2 (xx) 1999-04-21
TW438777B (en) 2001-06-07
CZ58199A3 (cs) 1999-06-16
AU721850B2 (en) 2000-07-13
HUP0001165A3 (en) 2002-02-28
PT923550E (pt) 2003-01-31
EP0923550B1 (en) 2002-09-25
NO990786D0 (no) 1999-02-19
DE69715886D1 (de) 2002-10-31
CA2264065A1 (en) 1998-02-26
ES2184083T3 (es) 2003-04-01
ID18059A (id) 1998-02-26
SK22199A3 (en) 2000-02-14
CN1233238A (zh) 1999-10-27
HU226395B1 (en) 2008-11-28
IL128631A0 (en) 2000-01-31
DE69715886T2 (de) 2003-05-15
NZ334736A (en) 2000-09-29
DK0923550T3 (da) 2003-01-06
NO312292B1 (no) 2002-04-22
CO4900047A1 (es) 2000-03-27
IL128631A (en) 2002-09-12
MY132550A (en) 2007-10-31
BR9711350A (pt) 1999-08-17
JP3654908B2 (ja) 2005-06-02
KR20000068325A (ko) 2000-11-25
CA2264065C (en) 2008-02-05
CZ294233B6 (cs) 2004-11-10
SK283991B6 (sk) 2004-07-07

Similar Documents

Publication Publication Date Title
HUP0001165A2 (hu) NK1 és NK2 antagonista hatású acil-amino-alkil-amid-származékok, a vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra
AR004493A1 (es) Derivados de oxindol 3- sustituido util como moduladores de canales de potasio y composiciones farmaceuticas que lo contienen.
AR006720A1 (es) Un compuesto derivado de azahexano heterociclico, su uso para la preparacion de una composicion farmaceutica, procedimiento para prepararlo y una composicion farmaceutica que lo comprende
HUP0000079A2 (hu) Indán- és dihidroindolszármazékok
ATE169008T1 (de) 3,5-dioxo-(2h,4h)-1,2,4-triazinderivate ihre herstellung und verwendung als medikament
HUP0102404A2 (hu) N-acilezett gyűrűs aminszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények
HUP0203136A2 (hu) Piperazinszármazékok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP9902471A2 (hu) Piperazin- és piperidinvegyületek, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
AR028531A1 (es) Compuestos organicos
HUP9901245A2 (hu) Endothelin-receptor antagonista hatású indolszármazékok, előállításuk és alkalmazásuk, a vegyületeket tartalmazó gyógyászati készítmények
DE69530094D1 (de) Thiazolidindione derivate, ihre herstellung und verwendung
MXPA01004854A (es) Nuevos compuestos de piperazina y piperidina.
DE69418789D1 (de) 2-(Piperidin-4-yl, Pyridin-4-yl und Tetrahydropyridin-4-yl)-benzofuran-7-carbamat Derivate, ihre Herstellung und Verwendung als Acetylcholinesterase Inhibitoren
ATE296300T1 (de) Benzoheterocyclische distamycinderivate, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel
FR2665441B1 (fr) Derives de la n-sulfonyl indoline, leur preparation, les compositions pharmaceutiques en contenant.
HU902129D0 (en) Process for producing tetrahydrobenzo-(c,d)-indole derivatives
HUP0004142A2 (hu) 5-HT1F agonista hatású karboxamidszármazékok és a vegyületeket tartalmazó gyógyászati készítmények
MY118004A (en) Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
DE69319925D1 (de) Indol-piperazin-derivate als selektive liganden der 5ht1d und 5ht1b receptoren verwendbar als arzneimittel
UY25970A1 (es) Derivado de indol para tratamiento de superproducción de dihidrotestosterona
YU43902A (sh) Novi razgranati supstituisani amino derivati od 3-amino-1- -fenil-1h(1,2,4) triazola, postupak za njihovo dobijanje i farmaceutski preparati koji ih sadrže
WO1999021848A3 (en) Novel 1-(n'-(arylalkylaminoalkyl))aminoisoindoles; a new class of dopamine receptor subtype specific ligands
TR200101808T2 (tr) Psikotik hastalıkların tedavisi için 3-tetrahidropiridin-4-il indoller
GB9812211D0 (en) Cinnamoyl distamycin analogous derivatives,process for their preparation,and their use as antitumor agents
HUP0000783A2 (hu) N-(piridinil-amino)-izoindolinok és származékaik, eljárás előállításukra, e vegyületeket tartalmazó gyógyszerkészítmények és alkalmazásuk

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees